Pegvaliase

培伐利酶

Report date: 2024/06/06 13:55:21
First In Class

Base Information

Drug NamePegvaliase
Drug Alias Nameペグバリアーゼ（遺伝子組換え）Pegvaliasum培伐利酶rAvPAL-PEGRecombinant Anabaena variabilis phenylalanine ammonia lyase +[13] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPhenylalanine ammonia-lyase replacements
TargetsPhenylalanine ammonia-lyase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsPhenylketonurias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/05/24
Country/TerritoryUnited StatesGermanyEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomarin Pharmaceutical IncBiomarin International Ltd
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeA16AB19
Related LinksN/A